203 related articles for article (PubMed ID: 37057133)
1. Synthesis, radiolabeling, and evaluation of a (4-quinolinoyl)glycyl-2-cyanopyrrolidine analogue for fibroblast activation protein (FAP) PET imaging.
Zhang N; Pan F; Pan L; Diao W; Su F; Huang R; Yang B; Li Y; Qi Z; Zhang W; Wu X
Front Bioeng Biotechnol; 2023; 11():1167329. PubMed ID: 37057133
[TBL] [Abstract][Full Text] [Related]
2.
Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
[TBL] [Abstract][Full Text] [Related]
3. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation and pilot clinical study of [
Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preclinical evaluation of novel
Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
[TBL] [Abstract][Full Text] [Related]
6. Design and Development of
Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
[TBL] [Abstract][Full Text] [Related]
7.
Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
[TBL] [Abstract][Full Text] [Related]
8.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
9. [
Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a
Fu L; Huang J; Liu Q; Xie F; Han Y; Sun P; Cao M; Huang Y; Hu K; Tang G
Bioorg Chem; 2023 Dec; 141():106878. PubMed ID: 37774434
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation and pilot clinical study of [
Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
13. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Preliminary Evaluation of
Ma H; Li F; Shen G; Cai H; Liu W; Lan T; Yang Y; Yang J; Liao J; Liu N
Mol Pharm; 2021 Nov; 18(11):4179-4187. PubMed ID: 34591481
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Preclinical Evaluation of Novel
Bendre S; Kuo HT; Merkens H; Zhang Z; Wong AAWL; Bénard F; Lin KS
Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375746
[TBL] [Abstract][Full Text] [Related]
17. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [
Linz C; Brands RC; Kertels O; Dierks A; Brumberg J; Gerhard-Hartmann E; Hartmann S; Schirbel A; Serfling S; Zhi Y; Buck AK; Kübler A; Hohm J; Lapa C; Kircher M
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3951-3960. PubMed ID: 34050405
[TBL] [Abstract][Full Text] [Related]
18. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
Lindner T; Loktev A; Altmann A; Giesel F; Kratochwil C; Debus J; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2018 Sep; 59(9):1415-1422. PubMed ID: 29626119
[TBL] [Abstract][Full Text] [Related]
19. Clinical translational evaluation of Al
Wang S; Zhou X; Xu X; Ding J; Liu S; Hou X; Li N; Zhu H; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4259-4271. PubMed ID: 34165601
[TBL] [Abstract][Full Text] [Related]
20. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]